These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Immunomodulation using an epidermal cytokine (ETAF)]. Luger TA, Niebauer G. Z Hautkr; 1984 Jan 01; 59(1):18, 23-34. PubMed ID: 6367244 [Abstract] [Full Text] [Related]
4. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. Sauder DN, Mounessa NL, Katz SI, Dinarello CA, Gallin JI. J Immunol; 1984 Feb 01; 132(2):828-32. PubMed ID: 6361134 [Abstract] [Full Text] [Related]
9. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity. Luger TA, Uchida A, Köck A, Colot M, Micksche M. J Immunol; 1985 Apr 01; 134(4):2477-83. PubMed ID: 3882831 [Abstract] [Full Text] [Related]
13. Biologic properties of the thymocyte-activating factor (CETAF) produced by a rabbit corneal cell line (SIRC). Grabner G, Luger TA, Luger BM, Smolin G, Oh JO. Invest Ophthalmol Vis Sci; 1983 May 01; 24(5):589-95. PubMed ID: 6841006 [Abstract] [Full Text] [Related]
14. Lymphokines: their role in lymphocyte responses. Properties of interleukin 1. Oppenheim JJ, Stadler BM, Siraganian RP, Mage M, Mathieson B. Fed Proc; 1982 Feb 01; 41(2):257-62. PubMed ID: 6800841 [Abstract] [Full Text] [Related]